Jan Willem specialises in international corporate finance with a focus on cross-border equity capital markets transactions. He advises corporates and financial institutions close to home and far afield. His regulatory practice ranges from buy-back programmes to cross-border clearing and settlement, and from block trades to insider trading issues.
For over a decade, Chambers and Legal 500 have consistently ranked Jan Willem in Tier 1 for equity capital markets, with Legal 500 welcoming him into their Equity Capital Markets Hall of Fame for the Netherlands. Clients describe him as “thorough, hands-on and practical.” Sources add: “He really digs into the detail and is likeable and easy to communicate with.” 
Jan Willem’s work includes advising
<ul><li>FrieslandCampina on the restructuring of its member financing</li><li>Van Lanschot Kempen on the simplification of its group structure</li><li>Royal Philips on the dual track IPO/M&amp;A process for its domestic appliances business </li><li>Stellantis on its listing in relation to the EUR 50 billion merger between Fiat Chrysler and Peugeot</li><li>Fugro on its EUR 250 million rights offering and the abolition of its depositary receipts </li><li>the underwriters on the aborted 3.5 billion Unibail-Rodamco rights offering</li><li>CM.com on its listing on Euronext Amsterdam through a business combination with a SPAC</li><li>Takeaway.com on the capital market aspects of its merger with Just Eat, including its listing on the LSE</li><li>Topicus and its founders on their strategic direction leading to a business combination and listing in Canada</li><li>on the dual track process and ultimate IPO of Philips Lighting</li><li>LeasePlan on its proposed IPO</li><li>ABN AMRO Group on its IPO</li><li>Royal BAM Group on its convertible bond</li><li>IMCD on its IPO and subsequent ABB offerings</li><li>Prosensa on its listing on Nasdaq and its subsequent take-private</li><li>Organon BioSciences on its proposed IPO</li></ul>

Janwillem hoevers

Jan Willem Hoevers

Partner

Constantijn specializes in corporate advisory. His primary focus is corporate law, including governance, advisory and mergers and acquisitions.
Constantijn regularly advises founder-led businesses and family-owned corporations, both listed and privately held, on their corporate structure and founder / family corporate governance.
Constantijn has extensive experience across the field of corporate law. A substantial part of his practice is cross-border, reflecting his experience in international transactions involving IPOs, corporate restructurings, joint ventures, and strategic deals.
Constantijn practised law at De Brauw London, where he advised large international companies and financial institutions on corporate and finance transactions involving multiple jurisdictions. 
Constantijn’s recent work includes advising:
<ul><li>CTP on its listing on Euronext</li><li>the underwriters on the IPO of CureVac on NASDAQ</li><li>CM.com on its listing on Euronext through a business combination with Dutch Star Companies One</li><li>the Dutch State on the launch of Invest-NL</li><li>IGEA on its listing on SIX Swiss exchange</li><li>Pre-IPO corporate structuring of a major software-as-a-service platform</li><li>Vitol on its joint venture with Sargeant Marine </li><li>Avast on the acquisition of AVG</li><li>Various state-owned companies on their governance and corporate structuring </li><li>Various founder-led and family-owned companies on transactions and structuring</li></ul>

Constantijn voogt

Constantijn Voogt

On 20 July 2016 the initial public offering of Patheon was priced at USD 21 per share and the shares will be listed on the New York Stock Exchange following closing on 26 July 2016. Patheon is a leading global provider of outsourced pharmaceutical development and manufacturing services and is one of the world’s largest contract drug manufacturers. It provides comprehensive solutions for both small molecule and large molecule biological pharmaceuticals. Following the IPO, Patheon has a market capitalization of around USD 3 billion. Patheon will sell 29,464,286 shares and DSM, as selling shareholder, will sell 4,761,905 of its 53.5 million shares in Patheon, resulting in approximately USD 618.75 million and USD 100 million in gross proceeds, respectively. De Brauw Team: Paul Cronheim, Constantijn Voogt, Jan Marten van Dijk, Tijmen Klein Bronsvoort, Eline Viersen, Pim van Leersum, Olav Klaver, Lotte Boon, Johan Valk, Jan Willem Hoevers, Vivian Lee and Josse Klijnsma.

Capital 
Markets

Home

Matter overview

IPO of Patheon N.V.

Breadcrumbs

De Brauw is widely recognised as a leading international law firm in the Netherlands. For nearly 150 years, we have been standing by our clients as a strong and spirited collective of leading legal experts. Through profound engagement with the business of our clients and a deep understanding of their ambitions, we build relationships of trust - some of which already stand for more than one hundred years.

De Brauw Blackstone Westbroek

On 20 July 2016 the initial public offering of Patheon was priced at USD 21 per share and the shares will be listed on the New York Stock Exchange following closing on 26 July 2016. Patheon is a leading global provider of outsourced pharmaceutical development and manufacturing services and is one of the world’s largest contract drug manufacturers. It provides comprehensive solutions for both small molecule and large molecule biological pharmaceuticals. Following the IPO, Patheon has a market capitalization of around USD 3 billion. Patheon will sell 29,464,286 shares and DSM, as selling shareholder, will sell 4,761,905 of its 53.5 million shares in Patheon, resulting in approximately USD 618.75 million and USD 100 million in gross proceeds, respectively.  De Brauw Team: Paul Cronheim, Constantijn Voogt, Jan Marten van Dijk, Tijmen Klein Bronsvoort, Eline Viersen, Pim van Leersum, Olav Klaver, Lotte Boon, Johan Valk, Jan Willem Hoevers, Vivian Lee and Josse Klijnsma.

On 20 July 2016 the initial public offering of Patheon was priced at USD 21 per share and the shares will be listed on the New York Stock Exchange…

description

generator

law firm,lawyer,legal,legal firm,amsterdam,international law firm

keywords

https://dwbxnuhxoazve.cloudfront.net/Icons/_1200x630_crop_center-center_82_none/og_image.png?mtime=1710424428

https://www.linkedin.com/company/de-brauw-blackstone-westbroek/

https://www.facebook.com/careersatdebrauw

https://www.debrauw.com/matters/ipo-of-patheon-n-v

referrer

robots

twitter:card

twitter:creator

twitter:description

https://dwbxnuhxoazve.cloudfront.net/Icons/_800x418_crop_center-center_82_none/og_image.png?mtime=1710424428

Areas of expertise

Sector

Topic

Areas of expertise

Sector

Topic

IPO of Patheon N.V.

Team

Jan Willem Hoevers

Constantijn Voogt

Offices

Contact

Subscribe